期刊文献+

RP-HPLC法测定帕潘立酮原料药在大鼠体内的血药浓度及其药动学研究 被引量:1

Plasma Concentration and Pharmacokinetic Study of Paliperidone in Rats by RP-HPLC
原文传递
导出
摘要 目的:建立测定大鼠血浆中帕潘立酮浓度的方法并研究其药动学。方法:6只大鼠单剂量灌胃给予帕潘立酮2.5mg。以利培酮为内标,采用反相-高效液相色谱法测定给药前及给药后0.25、0.5、1、1.5、2、4、8、12、24、36、48h的血药浓度。采用DAS软件计算药动学参数。色谱柱为Scienhome KromasilC18,流动相为乙腈-0.1mol/L Na2HPO4(pH6.0)(62∶38),流速为1.0ml/min,检测波长为237nm,柱温为35℃,进样量为20μl。结果:帕潘立酮检测质量浓度的线性范围为0.01~0.40μg/m(lr=0.9995),方法回收率为98.7%~102.2%,萃取回收率为82.8%~85.8%,日内和日间RSD均<9%。帕潘立酮在大鼠体内吸收符合二室模型,主要药动学参数cmax为(102.3±21.56)μg/L、tmax为(1.5±0.22)h、t1/2β为(14.969±5.651)h、Vd为(17.568±9.688)L、AUC0-48h为(1799.721±329.573)μg·h/L。结论:本方法适用于帕潘立酮的血药浓度测定;帕潘立酮在大鼠体内消除较慢,分布较广。 OBJECTIVE: To establish the method for the determination of paliperidone (PA) concentration in the rat plasma, and to study pharmacokinetics of PA in rats. METHODS: 6 rats were given a single dose of 2.5 mg PA. The plasma concentration of PA was determined by RP-HPLC before medication and 0.25, 0.5, 1, 1.5, 2, 4, 8, 12, 24, 36, 48 h after medication, using risperidone as internal standard. Pharmaceutical parameters were calculated with DAS software. The analytic column was Scienhome Kromasil C18, with acetonitrile-0.1 mol/L Na2HPO4 (pH 6.0) (62 : 38) at the flow rate of 1.0 ml/min. The detection wavelength was set at 237 nm and column temperature was 35 ℃. The injection volume was 20 μl. RESULTS: The linear range of PA were 0.01- 0.40 μg/ml (r=0.999 5). The method recoveries were 98.7%-102.2%, and extraction recoveries were 82.8%-85.8%. RSD of inter-day and intra-day were less than 9 %. The plasma concentration-time curve of PA was fitted to two-compartment open pharmacokinetic model. The main pharmacokinetic parameters were as follows:cmax was (102.3 ± 21.56) μg/L; tmax was (1.5 ± 0.22) h; t1/2β was (14.969 ± 5.651) h; Vd was(17.568 ± 9.688) L; AUC0-48h was (1 799.721 ± 329.573) μg.h/L. CONCLUSIONS: This method is suitable for the determination of PA concentration in rat plasma. PA is eliminated slowly and then distributed widely in rats in vivo.
出处 《中国药房》 CAS CSCD 2013年第17期1569-1571,共3页 China Pharmacy
关键词 帕潘立酮 反相-高效液相色谱法 血药浓度 大鼠 Paliperidone RP-HPLC Plasma concentration Rats
  • 相关文献

参考文献4

二级参考文献16

  • 1Zhi-ling ZHOU,Xin LI,Huai-yan PENG,Xi-yong YU,Ming YANG,Feng-li SU,Feng WANG,Rong-hua ZHU,Chun-yu DENG,Qiu-xiong LIN,Chuan-yue WANG,Wen-biao LI,Shu-guang LIN,Huan-de LI.Multiple dose pharmacokinetics of risperidone and 9-hydroxyrisperidone in Chinese female patients with schizophrenia[J].Acta Pharmacologica Sinica,2006,27(3):381-386. 被引量:3
  • 2US FDA.FDA Approves New Drug for Schizophrenia[EB/OL].[2006-12-20].http://www.fda.gov/News-Events/ Newsroom/PressAnnouncernents/2006/ucm108812.htm.
  • 3Kankan RN,Rao DR,Pathi SL.Process for the preparation of paliperidone and pharmaceutically acceptable salts thereof and intermediates for use in the processes:WO,2009047499[P].2009-04-16.(CA 2009,150:423221).
  • 4Barti J,Benovsky E Krajcovic J.Synthesis of paliperidone:WO,2009074333[P].2009-06-18.(CA2009,151:56864).
  • 5Dolitzky BZ,Shapiro E,Ini S,et al.Process for the synthesis of CMHTP and intermediates thereof:US,20080214809[P].2008-09-04.(CA 2008,149:307878).
  • 6Bristol JA,Gross I,Lovey RG.An improved synthesis of 2-amino-3-alkyloxypyridines by a phase-transfer catalyzed ether synthesis[J].Synthesis,1981,(12):971-973.
  • 7Dehmlow EV.Advances in phase-transfer catalysis[J].Angew Chem Int EdEngl,1977,16 (8):493-505.
  • 8Ravi JRR,Pulla Reddy M,Adibhatla Kali Satya BR,et al.An improved,industrially viable process for the preparation of high purity paliperidone:WO,2009010988[P].2009-01-22.(CA2009,150:168378).
  • 9Ravi JRR,Pulla Reddy M,Adibhatla Kali Satya BR,et al.Stable polymorphic form of paliperidone and process for its preparation:WO,2009016653[P].2009-02-05.(CA 2009,150:199278).
  • 10于欣,侯也之,舒良,王秀玲,李冰,刘卫红,林凯,杨顺才,宋丽华,廖安燕,谢家康,贾宏晓,张继志.利培酮治疗精神分裂症的开放性临床验证[J].中华精神科杂志,1997,30(2):79-82. 被引量:330

共引文献16

同被引文献12

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部